Telix Pharmaceuticals Balance Sheet 2023-2025 | TLX

Fifteen years of historical annual and quarterly balance sheets for Telix Pharmaceuticals (TLX).

Annual Data | Millions of US $ except per share data

Metric Name
Cash On Hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity
20242023
$469$81.88
$91.99$43.04
$25.16$11.50
$0$0
$20.21$18.06
$606$154
$29.65$15.39
$0$0
$275$72.86
$53.22$8.15
$394$115
$1,000$270
$218$110
$369$10.55
$31.31$50.34
$407$61.11
$626$171
$394$297
$-140.49$-175.18
$0$0
$105$19.36
$375$98.94
$1,000$270

Quarterly Data | Millions of US $ except per share data

Metric Name